{"pageContent": "Purpose: High intensity focused ultrasound is a minimally invasive treatment option for prostate cancer. Data from the literature show promising early oncological outcomes and a favorable side effect profile. This study is a preliminary report of the Italian experience (Perugia and Turin) of patients treated with the Sonablate(R)500 high intensity focused ultrasound device.", "metaData": {"source": "High-intensity focussed ultrasound\nhttps://pubmed.ncbi.nlm.nih.gov/21256723/"}}